Cargando…

Chest CT imaging features and severity scores as biomarkers for prognostic prediction in patients with COVID-19

BACKGROUND: Coronavirus disease 2019 (COVID-19) has become a pandemic. Few studies have explored the role of chest computed tomography (CT) features and severity scores for prognostic prediction. In this study, we aimed to investigate the role of chest CT severity score and imaging features in the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Shuchang, Chen, Chengyang, Hu, Yiqi, Lv, Wenzhi, Ai, Tao, Xia, Liming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723645/
https://www.ncbi.nlm.nih.gov/pubmed/33313194
http://dx.doi.org/10.21037/atm-20-3421
_version_ 1783620385310244864
author Zhou, Shuchang
Chen, Chengyang
Hu, Yiqi
Lv, Wenzhi
Ai, Tao
Xia, Liming
author_facet Zhou, Shuchang
Chen, Chengyang
Hu, Yiqi
Lv, Wenzhi
Ai, Tao
Xia, Liming
author_sort Zhou, Shuchang
collection PubMed
description BACKGROUND: Coronavirus disease 2019 (COVID-19) has become a pandemic. Few studies have explored the role of chest computed tomography (CT) features and severity scores for prognostic prediction. In this study, we aimed to investigate the role of chest CT severity score and imaging features in the prediction of the prognosis of COVID-19 patients. METHODS: A total of 134 patients (62 recovered and 72 deceased patients) with confirmed COVID-19 were enrolled. The clinical, laboratory, and chest CT (316 scans) data were retrospectively reviewed. Demographics, symptoms, comorbidities, and temporal changes of laboratory results, CT features, and severity scores were compared between recovered and deceased groups using the Mann-Whitney U test and logistic regression to identify the risk factors for poor prognosis. RESULTS: Median age was 48 and 58 years for recovered and deceased patients, respectively. More patients had at least one comorbidity in the deceased group than the recovered group (60% vs. 29%). Leukocytes, neutrophil, high-sensitivity C-reactive protein (hsCRP), prothrombin, D-dimer, serum ferritin, interleukin (IL)-2, and IL-6 were significantly elevated in the deceased group than the recovered group at different stages. The total CT score at the peak stage was significantly greater in the deceased group than the recovered group (20 vs. 11 points). The optimal cutoff value of the total CT scores was 16.5 points, achieving 69.4% sensitivity and 82.2% specificity for the prognostic prediction. The crazy-paving pattern and consolidation were more common in the deceased patients than those in the recovered patients. Linear opacities significantly increased with the disease course in the recovered patients. Sex, age, neutrophil, IL-2, IL-6, and total CT scores were independent risk factors for the prognosis with odds ratios of 3.8 to 8.7. CONCLUSIONS: Sex (male), older age (>60 years), elevated neutrophil, IL-2, IL-6 level, and total CT scores (≥16) were independent risk factors for poor prognosis in patients with COVID-19. Temporal changes of chest CT features and severity scores could be valuable for early identification of severe cases and eventually reducing the mortality rate of COVID-19.
format Online
Article
Text
id pubmed-7723645
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-77236452020-12-10 Chest CT imaging features and severity scores as biomarkers for prognostic prediction in patients with COVID-19 Zhou, Shuchang Chen, Chengyang Hu, Yiqi Lv, Wenzhi Ai, Tao Xia, Liming Ann Transl Med Original Article BACKGROUND: Coronavirus disease 2019 (COVID-19) has become a pandemic. Few studies have explored the role of chest computed tomography (CT) features and severity scores for prognostic prediction. In this study, we aimed to investigate the role of chest CT severity score and imaging features in the prediction of the prognosis of COVID-19 patients. METHODS: A total of 134 patients (62 recovered and 72 deceased patients) with confirmed COVID-19 were enrolled. The clinical, laboratory, and chest CT (316 scans) data were retrospectively reviewed. Demographics, symptoms, comorbidities, and temporal changes of laboratory results, CT features, and severity scores were compared between recovered and deceased groups using the Mann-Whitney U test and logistic regression to identify the risk factors for poor prognosis. RESULTS: Median age was 48 and 58 years for recovered and deceased patients, respectively. More patients had at least one comorbidity in the deceased group than the recovered group (60% vs. 29%). Leukocytes, neutrophil, high-sensitivity C-reactive protein (hsCRP), prothrombin, D-dimer, serum ferritin, interleukin (IL)-2, and IL-6 were significantly elevated in the deceased group than the recovered group at different stages. The total CT score at the peak stage was significantly greater in the deceased group than the recovered group (20 vs. 11 points). The optimal cutoff value of the total CT scores was 16.5 points, achieving 69.4% sensitivity and 82.2% specificity for the prognostic prediction. The crazy-paving pattern and consolidation were more common in the deceased patients than those in the recovered patients. Linear opacities significantly increased with the disease course in the recovered patients. Sex, age, neutrophil, IL-2, IL-6, and total CT scores were independent risk factors for the prognosis with odds ratios of 3.8 to 8.7. CONCLUSIONS: Sex (male), older age (>60 years), elevated neutrophil, IL-2, IL-6 level, and total CT scores (≥16) were independent risk factors for poor prognosis in patients with COVID-19. Temporal changes of chest CT features and severity scores could be valuable for early identification of severe cases and eventually reducing the mortality rate of COVID-19. AME Publishing Company 2020-11 /pmc/articles/PMC7723645/ /pubmed/33313194 http://dx.doi.org/10.21037/atm-20-3421 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Zhou, Shuchang
Chen, Chengyang
Hu, Yiqi
Lv, Wenzhi
Ai, Tao
Xia, Liming
Chest CT imaging features and severity scores as biomarkers for prognostic prediction in patients with COVID-19
title Chest CT imaging features and severity scores as biomarkers for prognostic prediction in patients with COVID-19
title_full Chest CT imaging features and severity scores as biomarkers for prognostic prediction in patients with COVID-19
title_fullStr Chest CT imaging features and severity scores as biomarkers for prognostic prediction in patients with COVID-19
title_full_unstemmed Chest CT imaging features and severity scores as biomarkers for prognostic prediction in patients with COVID-19
title_short Chest CT imaging features and severity scores as biomarkers for prognostic prediction in patients with COVID-19
title_sort chest ct imaging features and severity scores as biomarkers for prognostic prediction in patients with covid-19
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723645/
https://www.ncbi.nlm.nih.gov/pubmed/33313194
http://dx.doi.org/10.21037/atm-20-3421
work_keys_str_mv AT zhoushuchang chestctimagingfeaturesandseverityscoresasbiomarkersforprognosticpredictioninpatientswithcovid19
AT chenchengyang chestctimagingfeaturesandseverityscoresasbiomarkersforprognosticpredictioninpatientswithcovid19
AT huyiqi chestctimagingfeaturesandseverityscoresasbiomarkersforprognosticpredictioninpatientswithcovid19
AT lvwenzhi chestctimagingfeaturesandseverityscoresasbiomarkersforprognosticpredictioninpatientswithcovid19
AT aitao chestctimagingfeaturesandseverityscoresasbiomarkersforprognosticpredictioninpatientswithcovid19
AT xialiming chestctimagingfeaturesandseverityscoresasbiomarkersforprognosticpredictioninpatientswithcovid19